Earnings Feed
Start Free
Home/Filings/3/0001181431-11-022768
3//SEC Filing

GENZYME CORP 3

Accession 0001181431-11-022768

CIK 0000732485operating
View on SEC.govCompany Profile

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 4:11 PM ET

Size

6.9 KB

Accession

0001181431-11-022768

Insider Transaction Report

Form 3
Period: 2011-04-05
GENZYME CORPGENZ
SANOFI-AVENTIS
10% Owner
Holdings

  • Common Stock, $0.01 par value

    (indirect: By GC Merger Corp.)
    184,038,545
GC Merger Corp.
10% Owner
Holdings

  • Common Stock, $0.01 par value

    (indirect: By GC Merger Corp.)
    184,038,545
Footnotes (2)
  • [F1]Reflects shares exchanged in an exchange offer.
  • [F2]The shares are held by GC Merger Corp. (the "Purchaser"). The Purchaser is direct wholly-owned subsidiary of sanofi-aventis ("Parent") and is the owner of the shares purchased in the exchange offer. The shares may also be deemed to be indirectly beneficially owned by Parent.

Documents

2 files

Issuer

GENZYME CORP

CIK 0000732485

→
Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000732485

Filing Metadata

Form type
3
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:11 PM ET
Size
6.9 KB
View on SEC.gov